Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Pathology and AI
Google releases open version of health AI developer platform
By
LabPulse.com staff writers
Tool supports medical AI imaging applications in pathology (Path Foundation), chest x-ray (CXR Foundation), and dermatology (Derm Foundation).
November 26, 2024
Proscia to offer Owkin's CRC test through platform
By
LabPulse.com staff writers
Digital pathology firm Proscia and artificial intelligence biotech company Owkin will collaborate to make Owkin's colorectal cancer (CRC) diagnostic test available through Proscia's digital pathology software platform.
November 20, 2024
Large language models tapped for speeding up clinical trial enrollment in U.S.
By
Liz Carey
Meanwhile, the FDA envisions integrating more clinical trial activities into local healthcare facilities, roaming mobile research units, and through at-home lab testing kits.
November 19, 2024
Flatiron to offer Tempus AI's testing through OncoEMR platform
By
LabPulse.com staff writers
Flatiron Health will incorporate comprehensive genetic testing from precision medicine firm Tempus AI directly into its cloud-based electronic medical record (EMR) platform.
November 13, 2024
Bio-Techne hematology devices receive IVDR certification
By
LabPulse.com staff writers
Bio-Techne has received In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology Controls and Calibrators.
November 12, 2024
Inify, Karolinska Institutet partner on AI-driven prostate cancer diagnostics
By
LabPulse.com staff writers
Digital pathology firm Inify Laboratories is collaborating with scientists at the Karolinska Institutet in Stockholm on a project aimed at improving the precision of prostate cancer diagnosis through artificial intelligence (AI)-driven image analysis.
November 5, 2024
Aignostics garners series B funding for AI-based offerings
By
LabPulse.com staff writers
Digital pathology firm Aignostics raised $34 million in series B funding, which it will use to fuel its growth in the U.S. and develop new models.
November 4, 2024
Lucy Letby murder case flags immunoassays as unreliable for medical evidence
By
Liz Carey
At least one pathologist has said it was wrong for scientists representing Liverpool Clinical Laboratories to insist insulin poisoning was the only explanation in a series of high-profile newborn deaths in the U.K., The Telegraph reported.
October 28, 2024
FDA grants breakthrough device designation to Invenio's lung biopsy image analysis module
By
LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Invenio for its image analysis module that is designed to assist physicians in evaluating bronchoscopic lung biopsies.
October 30, 2024
Digital pathology rollouts race for proof-of-concept at national level
By
Liz Carey
U.K. invests in clinical trial security while Australia's health minister issues powerful ultimatum.
October 29, 2024
Pathology groups' antitrust legal fight heats up
By
LabPulse.com staff writers
A lawsuit in which Iowa pathologists are suing their former colleagues is escalating, with one side accusing the other of attempting to maintain a monopoly at the expense of patients.
October 24, 2024
Mendaera raises $73M for handheld robotic platform
By
LabPulse.com staff writers
Healthcare tech firm Mendaera announced that it has raised $73 million in series B financing.
October 2, 2024
Page 1 of 179
Next Page